Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis
Conditions: Relapsing Remitting Multiple Sclerosis; Secondary Progressive Multiple Sclerosis; Primary Progressive Multiple Sclerosis Interventions: Drug: Rituximab; Drug: Ocrelizumab; Drug: Fexofenadine; Drug: Paracetamol; Drug: Methylprednisolone Sponsors: Rigshospitalet, Denmark; Odense University Hospital; Aarhus University Hospital; Aalborg University Hospital; Herlev Hospital; Hillerod Hospital, Denmark; Zealand University Hospital; Kolding Sygehus; Regional Hospital Holstebro; Hvidovre University Ho spital; Hospital of South We...
Source: ClinicalTrials.gov - December 30, 2020 Category: Research Source Type: clinical trials
Excipient Effect on Drug Absorption in Humans
Condition: The Impact of Excipients on Drug Absorption Interventions: Drug: Fexofenadine Hydrochloride without sodium lauryl sulfate; Drug: Fexofenadine Hydrochloride with sodium lauryl sulfate Sponsors: University of California, San Francisco; Food and Drug Administration (FDA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2020 Category: Research Source Type: clinical trials
